Latest News about EXAS
Recent news which mentions EXAS
2 Reasons to Buy Exact Sciences Stock, and 1 Reason to Sell
December 07, 2021
Tickers
EXAS
From Motley Fool
Exact Sciences Breaks Up With Pfizer -- Time to Buy?
December 01, 2021
From Motley Fool
The Daily Biotech Pulse: Cumberland Jumps On FDA Nod, Regeneron Says Antibody Treatment May Be Less Effective Against Omicron, ImmunoGen Readout
November 30, 2021
From Benzinga
From Benzinga
Cathie Wood Goes Bargain Shopping -- 3 Troubled Stocks She Just Bought
November 29, 2021
From Motley Fool
These 2 Cathie Wood Stocks Are Screaming Buys
November 24, 2021
From Motley Fool
3 Beaten-Down Genomics Stocks: Can They Recover?
November 16, 2021
From Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For November 3, 2021
November 03, 2021
From Benzinga
10 Biggest Price Target Changes For Wednesday
November 03, 2021
From Benzinga
25 Stocks Moving in Wednesday's Pre-Market Session
November 03, 2021
From Benzinga
Exact Sciences (EXAS) Q3 2021 Earnings Call Transcript
November 03, 2021
Tickers
EXAS
From Motley Fool
The Daily Biotech Pulse: Pfizer Reports Solid Q3 Earnings, Regulatory Setback For Legend, Lilly to Supply Additional COVID-19 Antibody Cocktails To US
November 02, 2021
From Benzinga
The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline
October 31, 2021
From Benzinga
If I Could Only Own 1 Healthcare Stock, This Is What It Would Be
October 21, 2021
From Motley Fool
The 1 Stock I'd Buy Right Now
September 18, 2021
From Motley Fool
3 Crash-Ready Stocks to Buy in September
September 14, 2021
From Motley Fool
This Cancer Screening Company Has A Better 5-Year Return Than Pfizer, Johnson & Johnson And Gilead
September 06, 2021
From Benzinga
3 Top Healthcare Stocks to Buy for August
August 19, 2021
From Motley Fool
10 Stocks to Buy From Cathie Wood’s Fleet of ETFs
August 06, 2021
From InvestorPlace
From InvestorPlace
44 Stocks Moving In Thursday's Mid-Day Session
July 29, 2021
From Benzinga
The Daily Biotech Pulse: Merck's Disappointing Q2, Atreca Falls On Data, FDA Nod For Viatris, Nuvalent, Icosavax IPOs
July 29, 2021
From Benzinga
28 Stocks Moving in Thursday's Pre-Market Session
July 29, 2021
From Benzinga
10 Stocks Moving In Wednesday's After-Hours Session
July 28, 2021
From Benzinga